News from AACR: DNA topoisomerases as a preferred target for new anticancer drugs April 13, 1999 No Comments
Pharmacokinetic evaluation of CDK inhibitor indicates need for short dosing interval April 13, 1999 No Comments
Calydon presents preclinical data on novel ARCA compound for prostate tumors April 12, 1999 No Comments
Design, preclinical toxicity of VNP-20009, a genetically modified Salmonella strain for solid tumors April 12, 1999 No Comments
Preclinical and clinical results with Virulizin in pancreatic cancer presented at AACR meeting April 12, 1999 No Comments
RSS